Patent US5496360A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5496360A Expired / Lapsed US ⏱️ 0.0 years remaining

Implantable cardiac electrode with rate controlled drug delivery

Assignee: Pacesetter Inc
•
Filing: 1994-04-12
•
Granted: 1996-03-05
•
Expires: 2014-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A body implantable electrode with rate controlled drug delivery is disclosed. A body implantable lead is provided for the delivery of stimulation energy to a desired body site includes a drug dispenser carried by the lead which retains a drug to be dispensed at least adjacent the desired body stimulation site. The drug may be one which is intended to counter thrombus formation, fibrosis, inflammation or arrhythmias, for example. The drug may be in liquid or powder form retained in a reservoir carried by the lead. The reservoir is formed as a pump which controls dispensing of the drug using a fluid drawing agent such as a salt.

Inventors

  • 👤 Drew A. Hoffmann
  • 👤 M. Elizabeth Bush

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 01:40
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/0565; A61N1/0568

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 98 words
An implantable device, comprising: an electrode for implantation in a patient, said electrode having a reservoir located within said electrode; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; at least one therapeutic drug carried in said reservoir; and at least one drawing agent contained in said reservoir, having an ability to draw body fluid into said reservoir for modulating drug delivery rate of said at least one therapeutic drug to body tissue.
Claim 2
Dependent Claim 98 words
An implantable device, comprising: an electrode for implantation in a patient, said electrode having a reservoir located within said electrode; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; at least one therapeutic drug carried in said reservoir; and at least one drawing agent contained in said reservoir, having an ability to draw body fluid into said reservoir for modulating drug delivery rate of said at least one therapeutic drug to body tissue.
Claim 3
Dependent Claim 11 words
The implantable device of claim 1, wherein said agent is hydrophilic.
Claim 4
Dependent Claim 11 words
The implantable device of claim 1, wherein said agent is lipophilic.
Claim 5
Dependent Claim 22 words
The implantable device of claim 1, wherein more than one said agent is contained in said reservoir to provide different pumping effects.
Claim 6
Dependent Claim 13 words
The implantable device of claim 2 wherein said hydrophilic agent is a salt.
Claim 7
Dependent Claim 13 words
The implantable device of claim 2 wherein said hydrophilic agent is a protein.
Claim 8
Dependent Claim 25 words
The implantable device of claim 1 and further including a polymeric matrix within said reservoir, wherein said drawing agent is impregnated in said polymeric matrix.
Claim 9
Dependent Claim 12 words
The implantable device of claim 7 wherein said polymeric matrix is biodegradable.
Claim 10
Dependent Claim 29 words
The implantable device of claim 2 and further including a polymeric matrix within said reservoir, wherein said hydrophilic agent comprises a hydrophilic species chemically attached to said polymeric matrix.
Claim 11
Dependent Claim 25 words
The implantable device of claim 1 and further including a polymeric matrix within said reservoir, wherein said therapeutic drug is impregnated in said polymeric matrix.
Claim 12
Dependent Claim 12 words
The implantable device of claim 9 wherein said polymeric matrix is biodegradable.
Claim 13
Dependent Claim 14 words
The implantable device of claim 1 wherein said therapeutic drug is in liquid form.
Claim 14
Dependent Claim 72 words
The implantable device of claim 1, wherein said drawing agent is impregnated in a first polymeric matrix, and said therapeutic drug is impregnated in a second polymeric matrix, and said drug and said drawing agent are separated by an impermeable membrane, said first polymeric matrix expanding upon solvation of said drawing agent to press on said drug and said second polymeric matrix with said impermeable membrane, causing said drug to be dispensed.
Claim 15
Dependent Claim 20 words
The implantable device of claim 1 wherein said drug and said drawing agent are mixed together into a polymeric matrix.
Claim 16
Dependent Claim 29 words
The implantable device of claim 1, and further comprising a barrier layer containing a drawing agent which must be dissolved before said drug can be dissolved to begin elution.
Claim 17
Dependent Claim 56 words
A pump for dispensing a therapeutic drug to a patient's body, comprising: a chamber containing a polymeric matrix, a therapeutic drug, and a hydrophilic agent, wherein said hydrophilic agent is embedded in said polymeric matrix; an electrically insulating material forming an outer wall of said chamber; and an electrode forming an inner wall of said chamber.
Claim 18
Dependent Claim 56 words
A pump for dispensing a therapeutic drug to a patient's body, comprising: a chamber containing a polymeric matrix, a therapeutic drug, and a hydrophilic agent, wherein said hydrophilic agent is embedded in said polymeric matrix; an electrically insulating material forming an outer wall of said chamber; and an electrode forming an inner wall of said chamber.
Claim 19
Dependent Claim 18 words
The pump of claim 16 wherein said electrode has a channel from said chamber to said patient's body.
Claim 20
Dependent Claim 88 words
A body implantable lead comprising: an electrode for sensing or stimulation for implantation in a patient's body; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; and a drug eluting system located within said electrode having at least one therapeutic drug and at least one fluid drawing agent for use as a pump for delivering said at least one therapeutic drug to tissue.
Claim 21
Dependent Claim 88 words
A body implantable lead comprising: an electrode for sensing or stimulation for implantation in a patient's body; an insulated conductor having a distal end and a proximal end and coupled to said electrode at said distal end of said conductor and having a connector at said proximal end of said conductor; and a drug eluting system located within said electrode having at least one therapeutic drug and at least one fluid drawing agent for use as a pump for delivering said at least one therapeutic drug to tissue.
Claim 22
Dependent Claim 22 words
The lead of claim 18, wherein said drug eluting system has a plurality of fluid drawing agents to provide different pumping effects.
Claim 23
Dependent Claim 12 words
The lead of claim 18 wherein said fluid drawing agent is lipophilic.
Claim 24
Dependent Claim 27 words
The body implantable lead of claim 18 and further comprising a polymeric matrix within said electrode, wherein said fluid drawing agent is impregnated in said polymeric matrix.
Claim 25
Dependent Claim 24 words
The lead of claim 18 and further comprising a polymeric matrix within said electrode, wherein said therapeutic drug is impregnated in said polymeric matrix.
Claim 26
Dependent Claim 11 words
The lead of claim 22 wherein said polymeric matrix is biodegradable.
Claim 27
Dependent Claim 44 words
The lead of claim 18 wherein said therapeutic drug and said fluid drawing agent are separated by an impermeable membrane, said fluid drawing agent expanding upon drawing of fluid to press on said drug with said impermeable membrane, causing said drug to be dispensed.
Claim 28
Dependent Claim 43 words
The lead of claim 18, and further comprising a chamber containing said drug and a fluid drawing agent which is embedded in a polymeric matrix, said chamber having an electrically insulating material forming an outer wall and said electrode forming an inner wall.
Claim 29
Dependent Claim 18 words
The lead of claim 25 wherein said electrode has a channel from said chamber to the patient's body,.
Claim 30
Dependent Claim 12 words
The lead of claim 25 wherein said electrically insulating material is semipermeable.
Claim 31
Dependent Claim 116 words
A drug eluting system for use in an implantable electrode comprising: a porous electrode; an outer chamber formed by a semipermeable electrically insulating material and containing at least one therapeutic drug; an inner chamber formed by a semipermeable membrane and containing a hydrophilic agent for use as an osmotic pump for delivering said at least one therapeutic drug to tissue; an impermeable membrane separating said outer chamber from said inner chamber, said semipermeable membrane allowing body fluid to pass through to said inner chamber, said hydrophilic agent expanding upon hydration to press on said drug with said impermeable membrane, causing said drug to be dispensed through said semipermeable electrically insulating material and through said porous electrode.
Claim 32
Dependent Claim 116 words
A drug eluting system for use in an implantable electrode comprising: a porous electrode; an outer chamber formed by a semipermeable electrically insulating material and containing at least one therapeutic drug; an inner chamber formed by a semipermeable membrane and containing a hydrophilic agent for use as an osmotic pump for delivering said at least one therapeutic drug to tissue; an impermeable membrane separating said outer chamber from said inner chamber, said semipermeable membrane allowing body fluid to pass through to said inner chamber, said hydrophilic agent expanding upon hydration to press on said drug with said impermeable membrane, causing said drug to be dispensed through said semipermeable electrically insulating material and through said porous electrode.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-03-05 1999-09-04 2000-03-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-03-05 2003-09-04 2004-03-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-03-05 2007-09-04 2008-03-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag